Maria Vadiaka

857 total citations
37 papers, 697 citations indexed

About

Maria Vadiaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Maria Vadiaka has authored 37 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Maria Vadiaka's work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Treatments and Mutations (7 papers). Maria Vadiaka is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (9 papers) and Lung Cancer Treatments and Mutations (7 papers). Maria Vadiaka collaborates with scholars based in Greece, United States and Russia. Maria Vadiaka's co-authors include Christos Kosmas, Nick B. Tsavaris, Νicolas Tsavaris, Nikolaos Malamos, Haralabos P. Kalofonos, Niki Stavroyianni, Michalis Efremidis, G. Stamatelos, Aristidis Polyzos and Gerassimos A. Pangalis and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Maria Vadiaka

37 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Vadiaka Greece 13 423 194 140 109 99 37 697
Atif Hussein United States 18 311 0.7× 221 1.1× 132 0.9× 60 0.6× 52 0.5× 59 829
William Nassib William United States 14 339 0.8× 267 1.4× 227 1.6× 50 0.5× 75 0.8× 44 810
Hiroshi Wakui Japan 15 412 1.0× 345 1.8× 233 1.7× 103 0.9× 29 0.3× 42 816
J. Shapira Israel 14 232 0.5× 149 0.8× 136 1.0× 58 0.5× 125 1.3× 41 672
Faruk Taş Türkiye 15 235 0.6× 99 0.5× 154 1.1× 95 0.9× 38 0.4× 44 585
Shinobu Kunugi Japan 14 188 0.4× 312 1.6× 186 1.3× 74 0.7× 41 0.4× 74 774
Çiğdem Usul Afşar Türkiye 14 178 0.4× 75 0.4× 123 0.9× 68 0.6× 67 0.7× 50 438
Urs von Holzen United States 15 302 0.7× 107 0.6× 180 1.3× 89 0.8× 47 0.5× 60 611

Countries citing papers authored by Maria Vadiaka

Since Specialization
Citations

This map shows the geographic impact of Maria Vadiaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Vadiaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Vadiaka more than expected).

Fields of papers citing papers by Maria Vadiaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Vadiaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Vadiaka. The network helps show where Maria Vadiaka may publish in the future.

Co-authorship network of co-authors of Maria Vadiaka

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Vadiaka. A scholar is included among the top collaborators of Maria Vadiaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Vadiaka. Maria Vadiaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kounatidis, Dimitris, et al.. (2021). Multiple mononeuritis with peripheral blood eosinophilia in a patient with Q fever: An unusual presentation: Case report and review of the literature. Journal of Infection and Chemotherapy. 27(9). 1357–1359. 2 indexed citations
2.
Kounatidis, Dimitris, et al.. (2020). Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review. Rheumatology International. 40(6). 997–1000. 2 indexed citations
3.
Efremidis, Michael, Konstantinos Vlachos, Κonstantinos P. Letsas, et al.. (2015). Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation. Journal of Electrocardiology. 48(5). 840–844. 11 indexed citations
4.
Efremidis, Michalis, Dimitrios Oikonomou, Κonstantinos P. Letsas, et al.. (2009). Predictors of atrial fibrillation recurrence in patients with long-lasting atrial fibrillation. Canadian Journal of Cardiology. 25(4). e119–e124. 11 indexed citations
5.
Sipsas, Nikolaos V., Christos Kosmas, Panayiotis D. Ziakas, et al.. (2007). Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: Ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate. Scandinavian Journal of Infectious Diseases. 39(9). 786–791. 5 indexed citations
6.
Tsavaris, Νicolas, et al.. (2006). Analgesic activity of high-dose intravenous calcitonin in cancer patients with bone metastases. Oncology Reports. 16(4). 871–5. 12 indexed citations
7.
Tsavaris, Νicolas, Christos Kosmas, & Maria Vadiaka. (2005). A simplified premedication schedule for 1-hour paclitaxel administration.. PubMed. 3(1). 77–81. 4 indexed citations
8.
Tsavaris, Νicolas, Christos Kosmas, Maria Vadiaka, et al.. (2002). Etoposide, Leucovorin (LV) and 5-Fluorouracil (5-FU) in 5-FU+LV Pre-Treated Patients with Advanced Colorectal Cancer. Journal of Chemotherapy. 14(4). 406–411. 3 indexed citations
9.
10.
Tsavaris, Nick B., et al.. (2002). Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. British Journal of Cancer. 87(1). 21–27. 269 indexed citations
11.
Tsavaris, Νicolas, et al.. (2002). Adenocarcinoma of the Colon Presenting as Polymyositis: Case Report. Journal of Chemotherapy. 14(1). 102–105. 4 indexed citations
12.
Tsavaris, Νicolas, Aris Polyzos, Christos Kosmas, et al.. (2002). Irinotecan (CPT-11) in Patients with Advanced Colon Carcinoma Relapsing after 5-Fluorouracil-Leucovorin Combination. Chemotherapy. 48(2). 94–99. 15 indexed citations
13.
Tsavaris, Νicolas, Christos Kosmas, Maria Vadiaka, et al.. (2002). Etoposide added to weekly leucovorin (LV)/5-fluorouracil (5-FU) in LV/5-FU pre-treated patients with advanced colorectal cancer.. PubMed. 8(9). PI65–9. 1 indexed citations
14.
Kosmas, Christos, et al.. (2002). Raltitrexed (Tomudex) Administration in Patients Failing Multiple Prior Chemotherapy Regimens in Advanced Colorectal Cancer: a Pilot Study. Investigational New Drugs. 20(1). 133–136. 2 indexed citations
15.
Kosmas, Christos, Νicolas Tsavaris, Maria Vadiaka, et al.. (2001). Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens. European Journal of Cancer. 37(8). 972–978. 32 indexed citations
16.
17.
Kosmas, Christos, Νicolas Tsavaris, Maria Vadiaka, et al.. (2001). Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens. Cancer. 92(11). 2902–2910. 33 indexed citations
18.
Kosmas, Christos, Νicolas Tsavaris, Thomas Makatsoris, et al.. (2001). A phase I‐II study of docetaxel‐ifosfamide‐cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer. International Journal of Cancer. 98(1). 141–147. 12 indexed citations
19.
Tsavaris, N., D. Skarlos, Gerasimos Aravantinos, et al.. (2000). Combined Treatment with Low-Dose Interferon plus Vinblastine Is Associated with Less Toxicity Than Conventional Interferon Monotherapy in Patients with Metastatic Renal Cell Carcinoma. Journal of Interferon & Cytokine Research. 20(8). 685–690. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atif Hussein Breakdown of academic impact, for papers by William Nassib William Breakdown of academic impact, for papers by Hiroshi Wakui Breakdown of academic impact, for papers by J. Shapira Breakdown of academic impact, for papers by Faruk Taş Breakdown of academic impact, for papers by Shinobu Kunugi Breakdown of academic impact, for papers by Çiğdem Usul Afşar Breakdown of academic impact, for papers by Urs von Holzen
Rankless by CCL
2026